[1]
R. C. Saputra and N. Hidayat, “Evaluation Effect of Tenofovir Alafenamide (TAF) in Long-Term Therapy for Chronic Hepatitis B: A Systematic Review”, InaJGHE, vol. 23, no. 3, pp. 217–226, Dec. 2022.